Liquidia Corporation (LQDA) NASDAQ
54.71
-4.0327(-6.86%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
54.71
-4.0327(-6.86%)
Currency In USD
Address
419 Davis Drive
Morrisville, NC 27560
United States of America (the)
Phone
919 328 4400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
170
First IPO Date
July 26, 2018
| Name | Title | Pay | Year Born |
| Roger A. Jeffs | Chief Executive Officer & Director | 2.12M | 1962 |
| Scott Moomaw | Chief Commercial Officer | 980,961 | 1971 |
| Rajeev Saggar | Chief Medical Officer | 1.17M | 1975 |
| Russell Schundler | General Counsel & Corporate Secretary | 1.17M | 1976 |
| Michael Kaseta | Chief Operating Officer & Chief Financial Officer | 1.41M | 1976 |
| Beth-Anne Lang | Senior Vice President of Global Regulatory Affairs | 0 | N/A |
| Dana Boyle | Chief Accounting Officer | 0 | 1985 |
| Frank Bartolini | Senior Vice President of Market Access | 0 | N/A |
| Harold Alterson | Senior Vice President of Quality | 0 | N/A |
| Michael Post | Senior Vice President of Marketing | 0 | N/A |
| Sarah Krepp SPHR | Chief Human Resources Officer | 0 | 1982 |
| Michael Hunter | Senior Vice President of Manufacturing Operations | 0 | N/A |
| Gareth Gwyn | Senior Vice President of Medical Affairs | 0 | N/A |
| Matt Snow | Senior Vice President of Sales | 0 | N/A |
| Jason Adair | Chief Business Officer | 0 | 1972 |
| Christian Perez Font | Senior Vice President, Chief Compliance Officer & Associate General Counsel | 0 | N/A |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.